ASCO PROSTATE: Survival After Radiation Plus Androgen Mirrors Healthy MenFebruary 27th 2007
KISSIMMEE, Fla. -- Radiation and androgen deprivation appears to bestow survival times for prostate cancer patients that are similar to the life expectancies of men of the same age who did not have cancer, researchers here reported.
ASCO PROSTATE: Imaging Not Helpful in Men With Low PSA in Biochemical FailureFebruary 27th 2007
KISSIMMEE, Fla. -- After definitive prostate cancer therapy, there is little value in imaging studies when patients with biochemical failure are asymptomatic and have PSA levels less than 5 ng/mL, researchers here reported.
ASCO PROSTATE: Potency Drugs Improve Sexual Function After Prostate Cancer TherapyFebruary 26th 2007
KISSIMMEE, Fla. -- Prostate cancer patients taking sildenafil (Viagra) or its ilk reported improved sexual functioning and interest following radiation therapy and radical prostatectomy, researchers here reported.
ASCO PROSTATE: Prostate Cancer Prevention Role Seen for BPH DrugFebruary 22nd 2007
KISSIMMEE, Fla. -- Dutasteride (Avodart), a drug used to treat benign prostatic hyperplasia, may also prevent the development of prostate cancer by inducing genetic changes at the cellular level, researchers reported today.
ASCO GI: Adjuvant Chemotherapy Plus Chemoradiation May Improve Pancreatic Cancer SurvivalJanuary 29th 2007
ORLANDO -- Gemzar (gemcitabine) plus Eloxatin (oxaliplatin) adjuvant chemotherapy, followed by chemoradiation ,can improve one-year post-resection recurrence-free survival in pancreatic cancer, suggests a small French study.
ASCO: GI Single-Agent Chemotherapy Improves Gastric Cancer SurvivalJanuary 19th 2007
ORLANDO -- Adjuvant chemotherapy with S-1, an oral prodrug of 5-fluorouracil (5-FU), improved survival compared with surgery alone, according to results of a phase III trial of 1,059 gastric cancer patients here reported here.